KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) Income from Continuing Operations (2016 - 2025)

Johnson & Johnson's Income from Continuing Operations history spans 17 years, with the latest figure at 5116000000.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations rose 49.11% year-over-year to 5116000000.0; the TTM value through Dec 2025 reached 26804000000.0, up 90.56%, while the annual FY2025 figure was 26804000000.0, 90.56% up from the prior year.
  • Income from Continuing Operations for Q4 2025 was 5116000000.0 at Johnson & Johnson, down from 5152000000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 10999000000.0 in Q1 2025 and bottomed at 491000000.0 in Q2 2023.
  • The 5-year median for Income from Continuing Operations is 4400000000.0 (2022), against an average of 4329750000.0.
  • The largest YoY upside for Income from Continuing Operations was 2616.23% in 2023 against a maximum downside of 110.94% in 2023.
  • A 5-year view of Income from Continuing Operations shows it stood at 3667000000.0 in 2021, then grew by 17.53% to 4310000000.0 in 2022, then skyrocketed by 43.69% to 6193000000.0 in 2023, then tumbled by 44.6% to 3431000000.0 in 2024, then surged by 49.11% to 5116000000.0 in 2025.
  • Per Business Quant, the three most recent readings for JNJ's Income from Continuing Operations are 5116000000.0 (Q4 2025), 5152000000.0 (Q3 2025), and 5537000000.0 (Q2 2025).